• Celebrate Your Colleagues on National Pharmacist Day 2023

    Published On: January 12, 2023Categories: Member News

    Pharmacy Time January 12, 2023 Aislinn Antrim   Pharmacists report a myriad of reasons for joining the profession, including the connections they can build with patients. National Pharmacist Day is celebrated annually on January 12, offering a day to celebrate the differences pharmacists make in patients’ lives each day. Pharmacists work in nearly every health care environment, including retail, hospitals, specialty pharmacy, and more. The profession is also growing, with an expected 2% growth between 2021 and 2031, according to the federal Bureau of Labor Statistics.1 Pharmacists play a key role in the health care system, far beyond dispensing medications. In addition to educating patients about their prescriptions and working daily to ensure medication compliance and provide medication therapy management [...]

    Read More
  • Opinion: Michigan patients deserve relief at the pharmacy counter

    Published On: December 9, 2022Categories: Member News

    As a leader of Plumbers UA Local 98, we are providers of a skilled workforce to Michigan’s biopharmaceutical industry, helping to construct needed research and manufacturing facilities to help produce and discover new cures. In providing this work, our members benefit from the health and welfare benefits connected to these construction jobs. Our members build the facilities where new medicines can help treat costly diseases. As union representatives, we also need to pay attention to the cost of coverage. Out-of-pocket health care costs rose by 3.9% in 2016, according to a new report by Health Affairs. That was the fastest rate of growth in nine years. And in 2016, national health care costs hit a new record — consuming about [...]

    Read More
  • Moderna Asks FDA to Approve Updated COVID-19 Vaccine

    Published On: August 24, 2022Categories: Member News

    Moderna has requested regulatory clearance of its reformulated COVID-19 vaccine, which the company is prepared to start delivering next month with FDA's authorization. The updated product is configured to fight the strain of coronavirus that emerged in 2019 as well as the Omicron BA.4 and BA.5 subvariants now in heavy circulation. Based on favorable results from previous evaluation of a version that targeted the original strain plus Omicron BA.1, Moderna CEO Stéphane Bancel says the new bivalent vaccine "may offer higher, broader, and more durable protection against COVID-19 compared to the currently authorized booster." A clinical trial is underway to assess the updated booster. Manufacturing team Pfizer-BioNTech, meanwhile, is preparing to launch a study this month of its own updated [...]

    Read More
  • Pfizer, BioNTech Seek FDA Authorization for Updated Covid-19 Vaccine

    Published On: August 23, 2022Categories: Member News

    Pfizer and BioNTech have applied for FDA authorization of their reformulated COVID-19 booster dose, which targets Omicron subtypes BA.4 and BA.5 as well as the original strain of SARS-CoV-2. Omicron cases are now dominant in the United States, but research has suggested that currently approved vaccines are less effective against the mutation and its subtypes. Human trials of the modified vaccine are only now about to kick off, according to the companies; however, animal studies yielded favorable results. The manufacturing partners are already making doses of the bivalent boosters and stand prepared to distribute them to the U.S. government ahead of a fall vaccination campaign. The goal is to blunt the effect of a potential surge in cases during the [...]

    Read More
  • From Meat to Insulin, How the Middlemen Economy Makes Everything More Expensive

    Published On: August 23, 2022Categories: Member News

    Time Magazine - Aug 23, 2022 The Federal Trade Commission recently launched an inquiry into the practices of pharmacy benefit managers, known in the industry as PBMs. PBMs are the hidden middlemen who were supposed to make drug distribution more efficient. Yet over time, they have grown in size and power, and research suggests they have contributed to the rapidly rising costs of prescription drugs, while taking home a growing chunk of those ballooning prices. The way that their growth and growing profits puts critical drugs out of reach for many, contributing to avoidable deaths and disease, may be extreme but it’s not an aberration. It is instead reflective of the way the growing size and power of middlemen is undermining the [...]

    Read More